“With the addition of compounded semaglutide [GLP-1], we are expanding our offering to include a clinical weight management solution that is both accessible and affordable,” said Interim Chief Executive Tara Comonte in prepared remarks.
More Stories
‘It’s just almost impossible to do it all’: Here’s how much time and money the sandwich generation is spending on eldercare
Presidential candidate Kamala Harris says family caregivers need more help.
Microsoft’s stock heads for a ‘death cross’ — but there are bigger chart problems
A chart of Microsoft’s stock will soon flash a clearly visible bearish signal that’s been in the works for the...
Hurricane Milton drives gas demand in Florida, with 16% of stations out of fuel
Hurricane Milton is one of the Atlantic Basin’s strongest storms on record and the frenzy of evacuations in Florida, where...
Big beer brands’ struggles seem likely to continue into next year, analyst says
Shares of some of the nation’s biggest brewers have slipped so far this year — and the months ahead don’t...
U.S. household energy bills shouldn’t shock consumers this winter
U.S. consumers won’t see much of a change in the cost to heat their homes this winter compared to last...
Social Security was only designed to help with 40% of your retirement — but think twice before choosing an annuity
Guaranteed income can be a tricky concept in retirement planning.